Di Wu
Di Wu
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma | Acral Melanoma | Recruiting | Phase 2 | 2021-05-26 | NCT04331093 |